ABA Chemicals Corporation
300261.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.12 | 0.61 | 4.93 | 8.55 |
| FCF Yield | 0.88% | -3.66% | -1.03% | 1.81% |
| EV / EBITDA | -54.65 | 99.55 | 25.99 | 46.65 |
| Quality | ||||
| ROIC | -7.75% | -1.37% | 6.56% | 6.15% |
| Gross Margin | 15.10% | 21.78% | 31.04% | 28.60% |
| Cash Conversion Ratio | -0.76 | 0.31 | 0.37 | 2.16 |
| Growth | ||||
| Revenue 3-Year CAGR | -15.62% | -14.85% | -0.04% | 7.57% |
| Free Cash Flow Growth | 122.29% | -137.06% | -132.85% | 35.72% |
| Safety | ||||
| Net Debt / EBITDA | -5.95 | 10.38 | 1.00 | 0.61 |
| Interest Coverage | -8.78 | -1.70 | 6.24 | 5.24 |
| Efficiency | ||||
| Inventory Turnover | 2.36 | 1.70 | 2.77 | 3.94 |
| Cash Conversion Cycle | 183.00 | 266.40 | 143.88 | 77.41 |